Literature DB >> 20078240

The rationale for identifying clinical predictors modifiable by tissue engineering for translational models.

Kurt P Spindler1, Warren R Dunn.   

Abstract

This article proposes a "bedside-to-bench" approach as a model to improve clinical outcomes for patients through functional tissue engineering (TE). The link between the highest level of clinical research and evaluation criteria for musculoskeletal TE is in identifying clinically proven predictors that are amenable to functional TE. The TE solutions developed in the laboratory should then be tested in translational models to evaluate efficacy and safety prior to controlled clinical trials. The best available evidence for potentially decreasing the incidence of radiographically confirmed osteoarthritis after anterior cruciate ligament injury is preservation of meniscus function. Meniscus tears occur concurrently in approximately 50% of anterior cruciate ligament tears. TE could promote repair of torn meniscus and/or replacement of meniscus loss because meniscus tear is a proven predictor of clinically relevant outcomes (such as osteoarthritis) in patients and is amenable to a potential TE solution.

Entities:  

Mesh:

Year:  2010        PMID: 20078240      PMCID: PMC2817668          DOI: 10.1089/ten.teb.2009.0302

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  12 in total

1.  Anterior cruciate ligament injuries in female athletes: Part 2, a meta-analysis of neuromuscular interventions aimed at injury prevention.

Authors:  Timothy E Hewett; Kevin R Ford; Gregory D Myer
Journal:  Am J Sports Med       Date:  2005-12-28       Impact factor: 6.202

Review 2.  Endoscopic versus rear-entry ACL reconstruction: a systematic review.

Authors:  Michael S George; Laura J Huston; Kurt P Spindler
Journal:  Clin Orthop Relat Res       Date:  2007-02       Impact factor: 4.176

3.  ACL reconstruction: a meta-analysis of functional scores.

Authors:  David J Biau; Caroline Tournoux; Sandrine Katsahian; Peter Schranz; Rémy Nizard
Journal:  Clin Orthop Relat Res       Date:  2007-05       Impact factor: 4.176

4.  Epidemiological approaches to heart disease: the Framingham Study.

Authors:  T R DAWBER; G F MEADORS; F E MOORE
Journal:  Am J Public Health Nations Health       Date:  1951-03

5.  A prospective, randomized study of three surgical techniques for treatment of acute ruptures of the anterior cruciate ligament.

Authors:  L Engebretsen; P Benum; O Fasting; A Mølster; T Strand
Journal:  Am J Sports Med       Date:  1990 Nov-Dec       Impact factor: 6.202

Review 6.  Anterior cruciate ligament reconstruction autograft choice: bone-tendon-bone versus hamstring: does it really matter? A systematic review.

Authors:  Kurt P Spindler; John E Kuhn; Kevin Blake Freedman; Charles E Matthews; Robert S Dittus; Frank E Harrell
Journal:  Am J Sports Med       Date:  2004-12       Impact factor: 6.202

7.  Evaluation criteria for musculoskeletal and craniofacial tissue engineering constructs: a conference report.

Authors: 
Journal:  Tissue Eng Part A       Date:  2008-12       Impact factor: 3.845

8.  Potential market for new meniscus repair strategies: evaluation of the MOON cohort.

Authors:  Gary B Fetzer; Kurt P Spindler; Annunziato Amendola; Jack T Andrish; John A Bergfeld; Warren R Dunn; David C Flanigan; Morgan Jones; Christopher C Kaeding; Robert G Marx; Matthew J Matava; Eric C McCarty; Richard D Parker; Michelle Wolcott; Armando Vidal; Brian R Wolf; Rick W Wright
Journal:  J Knee Surg       Date:  2009-07       Impact factor: 2.757

9.  Surgical or non-surgical treatment of acute rupture of the anterior cruciate ligament. A randomized study with long-term follow-up.

Authors:  C Andersson; M Odensten; L Good; J Gillquist
Journal:  J Bone Joint Surg Am       Date:  1989-08       Impact factor: 5.284

Review 10.  Clinical practice. Anterior cruciate ligament tear.

Authors:  Kurt P Spindler; Rick W Wright
Journal:  N Engl J Med       Date:  2008-11-13       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.